CD4 and neoplasm: The results showed that in all algorithms and cohorts, the low-risk group had higher numbers of plasma cells, NK cells, and certain CD4+ T cells (such as activated memory CD4+ T cells, Th1 cells, and Th2 cells), while tumor-associated fibroblasts (CAFs) showed the opposite trend.